Fundamentals

Nls Pharmaceutics Ltd.

NLSP

Soon

Sentiment

Soon

Options

Revenue

0.00

0.000.00%

-

Assets

4.34M

▲2.10M▲94.24%

6 Months Change

Liabilities

1.46M

▲628.36k▲76.00%

6 Months Change

Free Cash Flow

-4.27M

▲10.70M▲71.47%

36 Months Change

Revenue/Cost Of Revenue

Quarterly

Net Profit/Loss

Quarterly

Assets/Liabilities

Quarterly

Cash Flows

Quarterly

Quarterly

Outstanding Shares

Quarterly

Recent Quarterly and Annual Filings

ID: 0001213900-24-043570

ID: 0001213900-23-036920

ID: 0001213900-22-014905

ID: 0001213900-21-026511